Metastatic Colorectal Cancers Completed Phase 1 / 2 Trials for Sorafenib (DB00398)

Also known as: Colorectal cancer metastatic / Metastatic Colorectal Cancer

IndicationStatusPhase
DBCOND0063579 (Metastatic Colorectal Cancers)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00989469Sorafenib With Irinotecan in Metastatic Colorectal Cancer (mCRC) and K-RAS MutationTreatment